Visual Hallucinations in PD and Lewy Body Dementias: Old and New Hypotheses

Visual Hallucinations (VH) are a common non-motor symptom of Parkinson’s Disease (PD) and the Lewy body dementias (LBD) of Parkinson's disease with dementia (PDD) and Dementia with Lewy Bodies (DLB). The origin of VH in PD and LBD is debated: earlier studies considered a number of different possible mechanisms underlying VH including visual disorders, Rapid Eye Movement (REM) Sleep Intrusions, dysfunctions of top down or bottom up visual pathways, and neurotransmitter imbalance. More recently newer hypotheses introduce, among the possible mechanisms of VH, the role of attention networks (ventral and dorsal) and of the Default Mode Network (DMN) a network that is inhibited during attentional tasks and becomes active during rest and self referential imagery. Persistent DMN activity during active tasks with dysfunctional imbalance of dorsal and ventral attentional networks represents a new hypothesis on the mechanism of VH. We review the different methods used to classify VH and discuss reports supporting or challenging the different hypothetical mechanisms of VH.

[1]  P. Llorca,et al.  Prevalence and phenomenology of olfactory hallucinations in Parkinson's disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[2]  Daniel Weintraub,et al.  Psychosis in Parkinson's disease without dementia: Common and comorbid with other non‐motor symptoms , 2012, Movement disorders : official journal of the Movement Disorder Society.

[3]  E. Mori,et al.  Pareidolias: complex visual illusions in dementia with Lewy bodies , 2012, Brain : a journal of neurology.

[4]  R. Postuma,et al.  Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective study , 2012, Movement disorders : official journal of the Movement Disorder Society.

[5]  I. McKeith,et al.  Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study , 2012, The British journal of psychiatry : the journal of mental science.

[6]  M. Mikl,et al.  Default Mode Network and Extrastriate Visual Resting State Network in Patients with Parkinson’s Disease Dementia , 2012, Neurodegenerative Diseases.

[7]  John T. O'Brien,et al.  Functional connectivity in cortical regions in dementia with Lewy bodies and Alzheimer's disease , 2011, Brain : a journal of neurology.

[8]  E. Perry,et al.  Dreaming and hallucinations – Continuity or discontinuity? Perspectives from dementia with Lewy bodies , 2011, Consciousness and Cognition.

[9]  E. Tolosa,et al.  Cerebral basis of visual hallucinations in Parkinson's disease: Structural and functional MRI studies , 2011, Journal of the Neurological Sciences.

[10]  David R Williams,et al.  Testing an aetiological model of visual hallucinations in Parkinson's disease. , 2011, Brain : a journal of neurology.

[11]  I. McKeith,et al.  Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study , 2011, British Journal of Psychiatry.

[12]  G. Stebbins,et al.  Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years , 2011, Movement disorders : official journal of the Movement Disorder Society.

[13]  G. Halliday,et al.  Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks? , 2011, Movement disorders : official journal of the Movement Disorder Society.

[14]  D. Dickson,et al.  Neuropathology underlying clinical variability in patients with synucleinopathies , 2011, Acta Neuropathologica.

[15]  R. Armstrong,et al.  Visual Symptoms in Parkinson's Disease , 2011, Parkinson's disease.

[16]  M. Onofrj,et al.  Autoscopic phenomena: case report and review of literature , 2011, Behavioral and Brain Functions.

[17]  M. Catani,et al.  Disorders of visual perception , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  C. Jack,et al.  Dementia with Lewy bodies and Alzheimer disease , 2010, Neurology.

[19]  M. Onofrj,et al.  Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies , 2010, Neurology.

[20]  T. van Laar,et al.  Attentional and perceptual impairments in Parkinson's disease with visual hallucinations. , 2010, Parkinsonism & related disorders.

[21]  Carles Falcon,et al.  Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia , 2010, Movement disorders : official journal of the Movement Disorder Society.

[22]  E. Tolosa,et al.  Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  F. Cornelissen,et al.  Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. , 2009, Brain : a journal of neurology.

[24]  Oury Monchi,et al.  Dysfunction of the default mode network in Parkinson disease: a functional magnetic resonance imaging study. , 2009, Archives of neurology.

[25]  G. Stebbins,et al.  Hallucinations in Parkinson disease , 2009, Nature Reviews Neurology.

[26]  L. Moran,et al.  Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease. , 2009, Parkinsonism & related disorders.

[27]  Carlos Falcón,et al.  Brain response to complex visual stimuli in Parkinson's patients with hallucinations: A functional magnetic resonance imaging study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[28]  Klaus Leonard Leenders,et al.  Visual object recognition and attention in Parkinson's disease patients with visual hallucinations , 2008, Movement disorders : official journal of the Movement Disorder Society.

[29]  I. McKeith,et al.  A semi‐structured interview to assess visual hallucinations in older people , 2008, International journal of geriatric psychiatry.

[30]  Keith A. Johnson,et al.  Imaging amyloid deposition in Lewy body diseases , 2008, Neurology.

[31]  K. Nakashima,et al.  Executive dysfunction in non‐demented Parkinson’s disease patients with hallucinations , 2008, Acta neurologica Scandinavica.

[32]  J. Barnes,et al.  Executive functions are impaired in patients with Parkinson’s disease with visual hallucinations , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[33]  P. Barone,et al.  A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations , 2007, Movement disorders : official journal of the Movement Disorder Society.

[34]  A. Lees,et al.  Using the presence of visual hallucinations to differentiate Parkinson’s disease from atypical parkinsonism , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[35]  K. Nakashima,et al.  Clinical evaluation of Parkinson’s disease dementia: association with aging and visual hallucination , 2007, Acta neurologica Scandinavica.

[36]  Dag Aarsland,et al.  Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies , 2007, Neurology.

[37]  Mitsuyoshi Urashima,et al.  Impaired cardiovascular autonomic function in Parkinson's disease with visual hallucinations , 2007, Movement disorders : official journal of the Movement Disorder Society.

[38]  Dominic H. ffytche,et al.  Visual hallucinatory syndromes: past, present, and future , 2007, Dialogues in clinical neuroscience.

[39]  Klaus Podoll,et al.  Complex visual hallucinations , 2007 .

[40]  John T. O'Brien,et al.  Atrophy is associated with posterior cingulate white matter disruption in dementia with Lewy bodies and Alzheimer’s disease , 2007, NeuroImage.

[41]  E. Tolosa,et al.  Cognitive Changes in Parkinson’s Disease Patients with Visual Hallucinations , 2007, Dementia and Geriatric Cognitive Disorders.

[42]  Clifford R Jack,et al.  Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. , 2007, Brain : a journal of neurology.

[43]  David Eidelberg,et al.  Metabolic brain networks associated with cognitive function in Parkinson's disease , 2007, NeuroImage.

[44]  J. Morris,et al.  Clinical phenotype of Parkinson disease dementia , 2006, Neurology.

[45]  I. McKeith,et al.  Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[46]  G. Albani,et al.  Visual hallucinations in Parkinson's disease: Clues to separate origins , 2006, Journal of the Neurological Sciences.

[47]  Carme Junqué,et al.  Neuropsychological deficits in Parkinson's disease patients with visual hallucinations , 2006, Movement disorders : official journal of the Movement Disorder Society.

[48]  S. D. Penna,et al.  Cortical rhythms reactivity in AD, LBD and normal subjects: A quantitative MEG study , 2006, Neurobiology of Aging.

[49]  Robert Howard,et al.  Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity. , 2006, Brain : a journal of neurology.

[50]  S. Leurgans,et al.  The malignant course of "benign hallucinations" in Parkinson disease. , 2006, Archives of neurology.

[51]  Deborah C Mash,et al.  Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations. , 2006, Parkinsonism & related disorders.

[52]  W. Poewe,et al.  Long‐term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study , 2006, Movement disorders : official journal of the Movement Disorder Society.

[53]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.

[54]  Elizabeth Littlewood,et al.  Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[55]  C. Goetz,et al.  Hallucinations in Parkinson disease in the prelevodopa era , 2006, Neurology.

[56]  E. Perry,et al.  Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations , 2005, Behavioral and Brain Sciences.

[57]  Enrico Marchioni,et al.  Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[58]  L. Ferini-Strambi,et al.  Aggressive dream content without daytime aggressiveness in REM sleep behavior disorder , 2005, Neurology.

[59]  David R Williams,et al.  Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study , 2005, The Lancet Neurology.

[60]  I. McKeith,et al.  Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies , 2005, Psychiatry Research: Neuroimaging.

[61]  Luigi Trojano,et al.  Frontal dysfunction contributes to the genesis of hallucinations in non‐demented Parkinsonian patients , 2005, International Journal of Geriatric Psychiatry.

[62]  D. Ffytche Visual hallucinations and the charles bonnet syndrome , 2005, Current psychiatry reports.

[63]  H. Braak,et al.  Cognitive status correlates with neuropathologic stage in Parkinson disease , 2005, Neurology.

[64]  S. Papapetropoulos,et al.  Factors associated with drug–induced visual hallucinations in Parkinson's disease , 2005, Journal of Neurology.

[65]  M. Oda,et al.  The Relation Between Visual Hallucinations and Visual Evoked Potential in Parkinson Disease , 2005, Clinical neuropharmacology.

[66]  G. Stebbins,et al.  Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model , 2005, Movement disorders : official journal of the Movement Disorder Society.

[67]  G. Fénelon,et al.  Hallucinations in Parkinson's disease: A follow‐up study , 2005, Movement disorders : official journal of the Movement Disorder Society.

[68]  G. Stebbins,et al.  Hallucinations and sleep disorders in PD , 2005, Neurology.

[69]  G. Glover,et al.  Altered cortical visual processing in PD with hallucinations , 2004, Neurology.

[70]  C. Peretz,et al.  Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson’s disease , 2004, Journal of Neural Transmission.

[71]  A. Destée,et al.  Retinal involvement in dementia with Lewy bodies: A clue to hallucinations? , 2003, Annals of neurology.

[72]  M. J Firbank,et al.  Regional cerebral blood flow in Parkinson's disease with and without dementia , 2003, NeuroImage.

[73]  G. E. Smith,et al.  Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism , 2003, Neurology.

[74]  C. Goetz,et al.  Coping strategies for visual hallucinations in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[75]  Yuichi Inoue,et al.  Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[76]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[77]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[78]  M. Onofrj,et al.  HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[79]  M. Rossor,et al.  “—but who is that on the other side of you?” Extracampine hallucinations revisited , 2002, The Lancet.

[80]  W. Burke,et al.  The neural basis of Charles Bonnet hallucinations: a hypothesis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[81]  M. Onofrj,et al.  Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up , 2002, Neurological Sciences.

[82]  G. Halliday,et al.  Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. , 2002, Brain : a journal of neurology.

[83]  I G McKeith,et al.  Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI , 2001, Neurology.

[84]  R. Manni,et al.  Hallucinations, REM sleep, and Parkinson’s disease: A medical hypothesis , 2001, Neurology.

[85]  B. Boeve,et al.  Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy , 2001, Movement disorders : official journal of the Movement Disorder Society.

[86]  G. Wooten,et al.  Prospective study of hallucinations and delusions in Parkinson's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[87]  A. David,et al.  Visual hallucinations in Parkinson's disease: a review and phenomenological survey , 2001, Journal of neurology, neurosurgery, and psychiatry.

[88]  I. McKeith,et al.  A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia , 2001, International journal of geriatric psychiatry.

[89]  R. Stickgold,et al.  Dreaming and the brain: Toward a cognitive neuroscience of conscious states , 2000, Behavioral and Brain Sciences.

[90]  D. Ffytche,et al.  Visual hallucinatory syndromes and the anatomy of the visual brain. , 2000, Brain : a journal of neurology.

[91]  M. Onofrj,et al.  Leucopenia induced by low dose clozapine in Parkinson's disease recedes shortly after drug withdrawal. Clinical case descriptions with commentary on switch-over to olanzapine , 2000, Neurological Sciences.

[92]  Y. Agid,et al.  Hallucinations, REM sleep, and Parkinson’s disease , 2000, Neurology.

[93]  G. Fénelon,et al.  Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. , 2000, Brain : a journal of neurology.

[94]  R. Raman,et al.  Decreased color discrimination and contrast sensitivity in Parkinson’s disease , 2000, Journal of the Neurological Sciences.

[95]  D. Ffytche,et al.  The perceptual consequences of visual loss: 'positive' pathologies of vision. , 1999, Brain : a journal of neurology.

[96]  E. Perry,et al.  Acetylcholine in mind: a neurotransmitter correlate of consciousness? , 1999, Trends in Neurosciences.

[97]  S. Yamaguchi,et al.  Medication-induced hallucination and cerebral blood flow in Parkinson’s disease , 1999, Journal of Neurology.

[98]  I. Anjegård,et al.  [Two cases of peduncular hallucinosis. Vivid, colorful and dancing images and figures]. , 1999, Lakartidningen.

[99]  S. Leurgans,et al.  Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.

[100]  D. Ffytche,et al.  The anatomy of conscious vision: an fMRI study of visual hallucinations , 1998, Nature Neuroscience.

[101]  F. Andermann,et al.  Complex visual hallucinations. Clinical and neurobiological insights. , 1998, Brain : a journal of neurology.

[102]  S. Leurgans,et al.  Poor visual discrimination and visual hallucinations in Parkinson's disease. , 1998, Clinical neuropharmacology.

[103]  C. Tanner,et al.  Early dopaminergic drug-induced hallucinations in parkinsonian patients , 1998, Neurology.

[104]  Y. Inoue,et al.  Night‐time hypnopompic visual hallucinations related to REM sleep disorder , 1998, Psychiatry and clinical neurosciences.

[105]  A. Korczyn,et al.  Auditory hallucinations in Parkinson’s disease , 1998, Journal of neurology, neurosurgery, and psychiatry.

[106]  G. Stebbins,et al.  Intravenous levodopa in hallucinating Parkinson's disease patients , 1998, Neurology.

[107]  R. Melzack,et al.  Properties of Complex Hallucinations Associated with Deficits in Vision , 1996, Perception.

[108]  Mark W. Mahowald,et al.  Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder , 1996, Neurology.

[109]  E. Perry,et al.  Acetylcholine and Hallucinations - Disease-Related Compared to Drug-Induced Alterations in Human Consciousness , 1995, Brain and Cognition.

[110]  C. Tanner,et al.  Polysomnographic sleep measures in Parkinson's disease patients with treatment‐induced hallucinations , 1993, Annals of neurology.

[111]  R. Melzack,et al.  Visual Hallucinations and Mental State: A Study of 14 Charles Bonnet Syndrome Hallucinators , 1993, The Journal of nervous and mental disease.

[112]  M. Onofrj,et al.  Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[113]  T. Di Paolo,et al.  Decreased dopamine in the retinas of patients with Parkinson's disease. , 1990, Investigative ophthalmology & visual science.

[114]  D. Levine,et al.  Peduncular hallucinosis associated with isolated infarction of the substantia nigra pars reticulata , 1990, Annals of neurology.

[115]  M. Ghilardi,et al.  Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. , 1988, Brain : a journal of neurology.

[116]  M. Ghilardi,et al.  Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[117]  M W Mahowald,et al.  Chronic behavioral disorders of human REM sleep: a new category of parasomnia. , 1986, Sleep.

[118]  M. Onofrj,et al.  Dopaminergic deficiency causes delayed visual evoked potentials in rats , 1982, Annals of neurology.

[119]  C. Goetz,et al.  Pharmacology of hallucinations induced by long-term drug therapy. , 1982, The American journal of psychiatry.

[120]  M. Onofrj,et al.  SYSTEM DISEASES AND VISUAL EVOKED POTENTIAL DIAGNOSIS IN NEUROLOGY: CHANGES DUE TO SYNAPTIC MALFUNCTION * , 1980, Annals of the New York Academy of Sciences.

[121]  M. Yahr,et al.  Measurements of visual evoked potentials in Parkinson's disease. , 1978, Brain : a journal of neurology.

[122]  H. Klawans,et al.  Levodopa-induced psychosis: a kindling phenomenon. , 1978, The American journal of psychiatry.

[123]  O. Sacks,et al.  Effects of levodopa in parkinsonian patients with dementia , 1972, Neurology.

[124]  A. Damasio,et al.  Psychiatric aspects in Parkinsonism treated with L-dopa , 1971, Journal of neurology, neurosurgery, and psychiatry.

[125]  G. Celesia,et al.  Psychosis and other psychiatric manifestations of levodopa therapy. , 1970, Archives of neurology.

[126]  D. Ross,et al.  Mental Symptoms in Parkinsonism following Benzhexol Hydrochloride Therapy , 1956, British medical journal.

[127]  H. König Zur Psychopathologie der Paralysis agitans , 1912, Archiv für Psychiatrie und Nervenkrankheiten.

[128]  J. Barnesa,et al.  Reality monitoring and visual hallucinations in Parkinson ’ s disease , 2015 .

[129]  Federica Provini Agrypnia Excitata , 2013, Current Neurology and Neuroscience Reports.

[130]  M. Onofrj,et al.  Symptomatic REM sleep behaviour disorder , 2007, Neurological Sciences.

[131]  Thomas Benke,et al.  Peduncular hallucinosis: a syndrome of impaired reality monitoring. , 2006, Journal of neurology.

[132]  G. Celesia The mystery of photopsias, visual hallucinations, and distortions. , 2006, Supplements to Clinical neurophysiology.

[133]  B. Sharf,et al.  Dream phenomena induced by chronic levodopa therapy , 2005, Journal of Neural Transmission.

[134]  F Aichner,et al.  Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. , 2002, Neurology.

[135]  W. Kuhn,et al.  Effects of apomorphine on visual functions in Parkinson's disease , 2000, Journal of Neural Transmission.

[136]  Nir Giladi,et al.  Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease , 2000, Journal of Neural Transmission.

[137]  K. Jellinger,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.

[138]  S. Factor,et al.  Parkinson's disease: drug-induced psychiatric states. , 1995, Advances in neurology.

[139]  P Thompson,et al.  Monoaminergic activities in Lewy Body dementia: Relation to hallucinosis and extrapyramidal features , 1993, Journal of neural transmission. Parkinson's disease and dementia section.

[140]  L. Cote,et al.  Treatment of drug-induced psychosis in Parkinson's disease with clozapine. , 1993, Advances in neurology.

[141]  楢林 博太郎 Parkinson's disease : from basic research to treatment , 1993 .

[142]  M. Tagliati,et al.  The visual system in Parkinson's disease. , 1993, Advances in neurology.

[143]  W. Weiner,et al.  Sleep disorders and sleep effect in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.

[144]  M. Ghilardi,et al.  Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. , 1988, Life sciences.

[145]  P. Rondot,et al.  Mental disorders in Parkinson's disease after treatment with L-DOPA. , 1984, Advances in neurology.

[146]  H. Maudsley Paralysis agitans. , 1953, The Medical journal of Australia.

[147]  F. Lewy Die Lehre vom Tonus und der Bewegung : Zugleich systematische Untersuchungen zur Klinik, Physiologie, Pathologie und Pathogenese der paralysis Agitans , 1923 .